Antiplatelet therapy in the elderly - Aspirin, ticlopidine-clopidogrel, and GPIIb/GPIIIa antagonists

被引：11

作者：

Calverley, DC ^{[1
]}

机构：

[1] Univ So Calif, Dept Med, Div Hematol, Los Angeles, CA 90033 USA

来源：

CLINICS IN GERIATRIC MEDICINE | 2001年 / 17卷 / 01期

关键词：

D O I：

10.1016/S0749-0690(05)70104-X

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

Aspirin is the most widely used antithrombotic agent and has a proven role in the prevention and acute management of atherosclerosis-associated arterial thrombotic events. More recently developed antiplatelet agents have been found to have specific prophylactic roles associated with percutaneous coronary intervention and other clinical settings. This article outlines pharmacologic considerations and current clinical knowledge relevant to the use of aspirin, ticlopidine, clopidogrel, and the GPIIb/GPIIIa antagonists in the management of patients with thrombotic disorders.

引用

页码：31 / +

页数：19

共 137 条

[1] Antithrombotic and thrombolytic therapy for ischemic stroke [J].

Albers, GW ;

Easton, JD ;

Sacco, RL ;

Teal, P .

CHEST, 1998, 114 (05) :683S-698S

[2] ATRIAL-FIBRILLATION AND STROKE - 3 NEW STUDIES, 3 REMAINING QUESTIONS [J].

ALBERS, GW .

ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (13) :1443-1448

[3] Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia [J].

Algra, A ;

vanGijn, J .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 60 (02) :197-199

[4] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].

ALTMAN, R ;

CARRERAS, L ;

DIAZ, R ;

FIGUEROA, E ;

PAOLASSO, E ;

PARODI, JC ;

CADE, JF ;

DONNAN, G ;

EADIE, MJ ;

GAVAGHAN, TP ;

OSULLIVAN, EF ;

PARKIN, D ;

RENNY, JTG ;

SILAGY, C ;

VINAZZER, H ;

ZEKERT, F ;

ADRIAENSEN, H ;

BERTRANDHARDY, JM ;

BRAN, M ;

DAVID, JL ;

DRICOT, J ;

LAVENNEPARDONGE, E ;

LIMET, R ;

LOWENTHAL, A ;

MORIAU, M ;

SCHAPIRA, S ;

SMETS, P ;

SYMOENS, J ;

VERHAEGHE, R ;

VERSTRAETE, M ;

ATALLAH, A ;

BARNETT, H ;

BATISTA, R ;

BLAKELY, J ;

CAIRNS, JA ;

COTE, R ;

CROUCH, J ;

EVANS, G ;

FINDLAY, JM ;

GENT, M ;

LANGLOIS, Y ;

LECLERC, J ;

NORRIS, J ;

PINEO, GF ;

POWERS, PJ ;

ROBERTS, R ;

SCHWARTZ, L ;

SICURELLA, J ;

TAYLOR, W ;

THEROUX, P .

BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100

[5]

[Anonymous], 1974, BMJ-BRIT MED J, V1, P440

[6]

[Anonymous], 1988, LANCET, V2, P349

[7]

[Anonymous], 1988, BRIT MED J, V296, P320

[8]

[Anonymous], 1991, Lancet, V338, P1345

[9] MULTICENTER DOUBLE-BLIND-STUDY OF TICLOPIDINE IN THE TREATMENT OF INTERMITTENT CLAUDICATION AND THE PREVENTION OF ITS COMPLICATIONS [J].

ARCAN, JC ;

BLANCHARD, J ;

BOISSEL, JP ;

DESTORS, JM ;

PANAK, E .

ANGIOLOGY, 1988, 39 (09) :802-811

[10] PROTEIN-KINASE-C, CALCIUM AND PHOSPHOLIPID DEGRADATION [J].

ASAOKA, Y ;

NAKAMURA, S ;

YOSHIDA, K ;

NISHIZUKA, Y .

TRENDS IN BIOCHEMICAL SCIENCES, 1992, 17 (10) :414-417

← 1 2 3 4 5 6 7 8 9 10 →